IONS
NASDAQ · Biotechnology
Ionis Pharmaceuticals Inc
$75.71
-0.31 (-0.41%)
Performance
1D
—
1W
—
1M
—
3M
-10.71%
6M
+4.50%
1Y
+125.80%
YTD
-4.97%
Open$76.45
Previous Close$76.02
Day High$77.40
Day Low$75.24
52W High$86.74
52W Low$31.66
Volume—
Avg Volume2.07M
Market Cap12.45B
P/E Ratio—
EPS$-2.47
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$80.92
Below
SMA 200
$60.03
Above
RSI (14)
47.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
29 analysts
Price Target
-1.0% upside
Current
$75.71
$75.71
Target
$74.94
$74.94
$58.43
$74.94 avg
$113.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 970.05M | 828.25M | 6.52B |
| Net Income | -392,030,278 | -301,252,775 | -1,853,302,223 |
| Profit Margin | -40.4% | -38.4% | -28.4% |
| EBITDA | -473,166,648 | -383,801,498 | -2,518,216,651 |
| Free Cash Flow | — | — | -1,126,512,375 |
| Rev Growth | +17.1% | +17.1% | -9.9% |
| Debt/Equity | 4.77 | 4.77 | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |